News
Measles outbreaks have hit multiple U.S. states, vaccination & rapid reporting are critical to limit the spread & hospitalizations ...
New study details gaps between actual and recommended use of statins and other lipid-lowering drugs—and estimates public ...
Join Johns Hopkins Center for Alternatives to Animal Testing and the Physician's Committee for Responsible Medicine on July 1 for the third CAAT-PCRM Animal-Free Workshop for Early-Career Researchers, ...
The Public Health On Call podcast makes important public health topics accessible to all through quick, informative conversations. Hosts tackle complex topics through engaging interviews and ...
Lethal means safety counseling gives health care clinicians the tools they need to: Determine if a person at risk for injury or death has access to lethal means, including firearms, sharp instruments, ...
Protecting Health, Saving Lives—Millions at a TimeThe Johns Hopkins Center for Suicide Prevention, the first and only Center for Suicide Prevention at a school of public health, is engaged in ...
Pneumonia continues to be the leading infectious cause of death for children under 5, responsible for millions of hospitalizations and hundreds of thousands of child deaths worldwide. Most of these ...
Professor Ketner, a molecular microbiologist who studies the fundamental molecular biology of DNA-containing human viruses and their role in preventing diseases, will retire this summer.
Evaluation of candidate SARS-CoV2 vaccines is accelerating rapidly. However, currently registered trials exclude pregnant and lactating women (PLW), despite the fact that they have also been impacted ...
Gun-related suicides in the U.S. reached record highs in 2023, even as gun homicides continued to decline from their pandemic-era peak, according to a new report from the Center for Gun Violence ...
from the Center for Global Digital Health Innovation (CGDHI) at the Johns Hopkins Bloomberg School of Public Health explore how countries are building interoperable digital health systems to advance ...
The U.S. already pays more than other countries do for brand-name drugs. Tariffs could raise prices more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results